133 related articles for article (PubMed ID: 2878477)
1. Central effects of N-allyl,N'-methyl-barbital and N-allylmethyprylon in mice.
Yamamoto I; Tateoka Y; Kimura T; Yamazaki F; Hamajima K; Watanabe K; Ho IK
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):191-9. PubMed ID: 2878477
[TBL] [Abstract][Full Text] [Related]
2. N,N'-diallylbarbital potentiation of drug-induced sleep and motor incoordination.
Tateoka Y; Yamamoto I; Watanabe K; Ho IK
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):17-28. PubMed ID: 2872705
[TBL] [Abstract][Full Text] [Related]
3. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
[TBL] [Abstract][Full Text] [Related]
4. The prolonging effect of N,N'-diallylpentobarbital on the drug-induced sleep and motor incoordination.
Yamamoto I; Tateoka Y; Watanabe K; Nabeshima T; Fontenot HJ; Ho IK
Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):209-19. PubMed ID: 4081315
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)].
Yamamoto I
Yakugaku Zasshi; 2005 Jan; 125(1):73-120. PubMed ID: 15635282
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of N,N'-diallylpentobarbital potentiation of pentobarbital-induced sleep in mice.
Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):173-85. PubMed ID: 3659568
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
[TBL] [Abstract][Full Text] [Related]
8. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
[No Abstract] [Full Text] [Related]
9. Synthesis and pharmacological activity of 1,4-benzodiazepine derivatives.
Osman AN; el-Gendy AA; Omar RH; Wagdy L; Omar AH
Boll Chim Farm; 2002; 141(1):8-14. PubMed ID: 12064063
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsive properties of 5-allyl-(beta-hydroxy)propyl-N-phenylbarbituric acid and the corresponding lactone.
Czarnecki R; Sobański H
Farmaco Sci; 1980 Nov; 35(11):945-50. PubMed ID: 6108870
[TBL] [Abstract][Full Text] [Related]
11. The guinea-pig isolated atrium as a model system for the central actions of selected CNS stimulant and depressant drugs. Part 1: 3,3-Diakylglutarimide homologues and related drugs.
Arblaster CI; Cameron DW; Lavi Y; Laycock GM; Shulman A
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):503-47. PubMed ID: 2891885
[TBL] [Abstract][Full Text] [Related]
12. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
Marley RJ; Miner LL; Wehner JM; Collins AC
J Pharmacol Exp Ther; 1986 Sep; 238(3):1028-33. PubMed ID: 3746657
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities.
El Batran SA; Osman AE; Ismail MM; El Sayed AM
Inflammopharmacology; 2006 Mar; 14(1-2):62-71. PubMed ID: 16835715
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and neuropharmacology of cyclobutanecarboxylic acid derivatives.
Zirvi KA; Jarboe CH
Farmaco Sci; 1976 Feb; 31(2):152-8. PubMed ID: 1261667
[TBL] [Abstract][Full Text] [Related]
16. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological activity of newly-synthesized derivatives of 3,3-diethyl-2,4-pyridinedione. V. Relation between chemical structure and pharmacological activity.
Belcheva I; Stoytchev T
Acta Physiol Pharmacol Bulg; 1983; 9(4):37-47. PubMed ID: 6677062
[TBL] [Abstract][Full Text] [Related]
18. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
Ulloque RA; Chweh AY; Swinyard EA
J Pharmacol Exp Ther; 1986 May; 237(2):468-72. PubMed ID: 3009786
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and sedative-hypnotic effects of N3-allyl- and N1-allyl-5,6-substituted 2-thiouracil derivatives in mice.
Dramiński M; Turski K; Tateoka Y; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1370-3. PubMed ID: 9775432
[TBL] [Abstract][Full Text] [Related]
20. The 6-azauridine analogues possessing sedative and hypnotic effects.
Kimura T; Watanabe K; Koshigami M; Miyamoto K; Kondo S; Yamamoto I
Nucleic Acids Symp Ser; 1992; (27):199-200. PubMed ID: 1283907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
